Rating Change
HC Wainwright & Co. analysts initiated coverage on Sight Sciences, Inc. (NASDAQ:SGHT) with a rating of Buy on October 15, 2026.
HC Wainwright & Co. analysts initiated coverage on Sight Sciences, Inc.

At publication ·
Sight Sciences, Inc. (NASDAQ:SGHT) · new coverage
At a glance
HC Wainwright & Co. analysts initiated coverage on Sight Sciences, Inc. (NASDAQ:SGHT) with a rating of Buy on October 15, 2026.
Sight Sciences, Inc. operates in the Healthcare sector. The stock currently trades at $8.80 with a market capitalization of $437.8M. The stock has gained 164.3% over the past 52 weeks.
Analyst coverage from HC Wainwright & Co. provides professional research and price targets that many institutional investors reference when making allocation decisions. The consensus of analyst opinions — along with the range of price targets — helps frame market expectations for Sight Sciences, Inc.
Analyst ratings and price targets are one input among many for investment decisions. Historical studies show that consensus analyst recommendations have mixed predictive power on their own, but significant changes in consensus — such as multiple upgrades or downgrades in a short period — can be more meaningful signals.
Among the 10 most recent ratings: 6 Buy, 4 Hold, 0 Sell.
| Date | Firm | Rating | Price Target |
|---|---|---|---|
| Oct 15, 2026 | HC Wainwright & Co. | Buy | N/A |
| Oct 05, 2026 | Citigroup | Neutral | N/A |
| Aug 06, 2026 | UBS | Buy | N/A |
| Jul 08, 2026 | Citigroup | Neutral | N/A |
| May 28, 2026 | Citigroup | Neutral | N/A |
Related Tools: Analyst Ratings Dashboard | View SGHT Stock Page
A rating of Buy from HC Wainwright & Co. reflects the analyst's outlook on Sight Sciences, Inc. (NASDAQ:SGHT). Analyst ratings are one factor investors consider alongside earnings, valuation, and sector trends.
Browse recent upgrades and downgrades on our Analyst Ratings Dashboard or the SGHT forecast page.
Current market data
NASDAQ · SGHT
$8.70
Up: +$0.08 · +0.93%
Live quote updated
Keep reading